Gregor E Berger

Summary

Publications

  1. ncbi request reprint Bioactive lipids in schizophrenia
    Gregor E Berger
    ORYGEN Youth Health and ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Australia
    Int Rev Psychiatry 18:85-98. 2006
  2. ncbi request reprint Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial
    Gregor E Berger
    ORYGEN Research Centre incorporating the Early Psychosis Prevention and Intervention Centre EPPIC, University of Melbourne, Australia
    J Clin Psychiatry 68:1867-75. 2007
  3. doi request reprint Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study
    Gregor E Berger
    Department of Psychiatry, ORYGEN Research Centre, University of Melbourne, Parkville, Australia
    Neuropsychopharmacology 33:2467-73. 2008
  4. ncbi request reprint Polyunsaturated fatty acids in emerging psychosis
    Nilufar Mossaheb
    Department of Child and Adolescent Psychiatry, Medical University Vienna, Austria
    Curr Pharm Des 18:576-91. 2012
  5. ncbi request reprint Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years
    Gregor E Berger
    The Schloessli Clinic, Department of Research and Education, Schlösslistrasse 8, CH 8618 Oetwil am See, Switzerland
    J Clin Psychiatry 69:1702-14. 2008
  6. doi request reprint A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naïve and early-treated first episode psychosis
    Stephen J Wood
    Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Australia
    Schizophr Res 102:163-70. 2008
  7. doi request reprint Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: a longitudinal T2 relaxometry pilot study
    Stephen J Wood
    Melbourne Neuropsychiatry Centre, University of Melbourne, Australia
    Psychiatry Res 182:180-2. 2010
  8. doi request reprint The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: a longitudinal MRI study
    John Paul Nicolo
    Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Australia
    Schizophr Res 116:49-54. 2010
  9. doi request reprint Medial temporal lobe glutathione concentration in first episode psychosis: a 1H-MRS investigation
    Stephen J Wood
    Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Australia
    Neurobiol Dis 33:354-7. 2009
  10. ncbi request reprint Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study
    Gregor E Berger
    Orygen Youth Health Research Centre, Locked Bag 10, Parkville, Victoria, 3052, Australia
    Curr Pharm Des 18:570-5. 2012

Detail Information

Publications22

  1. ncbi request reprint Bioactive lipids in schizophrenia
    Gregor E Berger
    ORYGEN Youth Health and ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Australia
    Int Rev Psychiatry 18:85-98. 2006
    ..This review investigates the role of bioactive lipids in schizophrenia and its treatment, as well as its potential use in prevention...
  2. ncbi request reprint Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial
    Gregor E Berger
    ORYGEN Research Centre incorporating the Early Psychosis Prevention and Intervention Centre EPPIC, University of Melbourne, Australia
    J Clin Psychiatry 68:1867-75. 2007
    ..To investigate if ethyl-eicosapentaenoic acid (E-EPA) augmentation improves antipsychotic efficacy and tolerability in first-episode psychosis (FEP)...
  3. doi request reprint Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study
    Gregor E Berger
    Department of Psychiatry, ORYGEN Research Centre, University of Melbourne, Parkville, Australia
    Neuropsychopharmacology 33:2467-73. 2008
    ..Larger confirmatory studies of these postulated metabolic brain effects of E-EPA are warranted...
  4. ncbi request reprint Polyunsaturated fatty acids in emerging psychosis
    Nilufar Mossaheb
    Department of Child and Adolescent Psychiatry, Medical University Vienna, Austria
    Curr Pharm Des 18:576-91. 2012
    ..The neuroprotective potential of n-3 LC-PUFAs for indicated prevention, i.e. delaying transition to psychosis in high-risk populations needs to be further explored...
  5. ncbi request reprint Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years
    Gregor E Berger
    The Schloessli Clinic, Department of Research and Education, Schlösslistrasse 8, CH 8618 Oetwil am See, Switzerland
    J Clin Psychiatry 69:1702-14. 2008
    ..To assess dosing, efficacy, and tolerability of quetiapine fumarate in drug-naive first-episode psychosis...
  6. doi request reprint A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naïve and early-treated first episode psychosis
    Stephen J Wood
    Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Australia
    Schizophr Res 102:163-70. 2008
    ..Seemingly illness-related Cr/PCr elevations were also specific to the diagnosis of schizophrenia-spectrum disorder and seem worthy of future study...
  7. doi request reprint Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: a longitudinal T2 relaxometry pilot study
    Stephen J Wood
    Melbourne Neuropsychiatry Centre, University of Melbourne, Australia
    Psychiatry Res 182:180-2. 2010
    ..There was an increase in T(2) in the placebo group but not in the E-EPA group, suggesting a neuroprotective effect of E-EPA treatment. In addition, the smaller the increase in T(2), the greater the improvement in negative symptoms...
  8. doi request reprint The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: a longitudinal MRI study
    John Paul Nicolo
    Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Australia
    Schizophr Res 116:49-54. 2010
    ..Qualifying and quantifying the effect of atypical antipsychotics on the volume of the pituitary gland will determine whether this measure is valid as a future estimate of HPA-axis activation in psychotic populations...
  9. doi request reprint Medial temporal lobe glutathione concentration in first episode psychosis: a 1H-MRS investigation
    Stephen J Wood
    Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Australia
    Neurobiol Dis 33:354-7. 2009
    ..This study provides further evidence of significant perturbations in brain GSH in first episode psychosis, and supports a broader involvement of GSH in the pathophysiology of schizophrenia...
  10. ncbi request reprint Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study
    Gregor E Berger
    Orygen Youth Health Research Centre, Locked Bag 10, Parkville, Victoria, 3052, Australia
    Curr Pharm Des 18:570-5. 2012
    ..To investigate if low-dose lithium may counteract the microstructural and metabolic brain changes proposed to occur in individuals at ultra-high risk (UHR) for psychosis...
  11. doi request reprint Adhesio interthalamica in individuals at high-risk for developing psychosis and patients with psychotic disorders
    Tsutomu Takahashi
    Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Victoria, Australia
    Prog Neuropsychopharmacol Biol Psychiatry 32:1708-14. 2008
    ....
  12. doi request reprint Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome
    Patrick D McGorry
    Orygen Youth Health Research Centre, Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia
    J Clin Psychiatry 74:349-56. 2013
    ..The aim of this study was to determine which intervention was most effective at preventing transition to psychosis: cognitive therapy plus low-dose risperidone, cognitive therapy plus placebo, or supportive therapy plus placebo...
  13. ncbi request reprint Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study
    Stephen J Wood
    Melbourne Neuropsychiatry Centre, University of Melbourne, c o National Neuroscience Facility, 161 Barry Street, Carlton, Melbourne, Victoria 3053, Australia
    Arch Gen Psychiatry 63:969-76. 2006
    ..These studies have generally been negative, perhaps because gray and white matter volumes inaccurately assess the underlying dysfunction that might be predictive of outcome...
  14. doi request reprint Relational memory in first episode psychosis: implications for progressive hippocampal dysfunction after illness onset
    Cali F Bartholomeusz
    National Neuroscience Facility, Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne, Carlton South, Victoria, Australia
    Aust N Z J Psychiatry 45:206-13. 2011
    ....
  15. doi request reprint Pilot study evaluating the effect of massage therapy on stress, anxiety and aggression in a young adult psychiatric inpatient unit
    Belinda Garner
    ORYGEN Research Centre, Parkville, Vic, Australia
    Aust N Z J Psychiatry 42:414-22. 2008
    ..The aim of the present pilot study was to examine the effectiveness of a relaxation massage therapy programme in reducing stress, anxiety and aggression on a young adult psychiatric inpatient unit...
  16. ncbi request reprint Olfactory sensitivity through the course of psychosis: Relationships to olfactory identification, symptomatology and the schizophrenia odour
    Warrick J Brewer
    ORYGEN Research Centre, Melbourne, Victoria, Australia
    Psychiatry Res 149:97-104. 2007
    ..This may be linked to olfactory habituation effects, abnormal chemical processing or a genetic predisposition...
  17. ncbi request reprint Antibodies to infectious agents in individuals at ultra-high risk for psychosis
    G Paul Amminger
    ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Australia
    Biol Psychiatry 61:1215-7. 2007
    ..While there is evidence that some cases of schizophrenia may be associated with microbial infections, the role of microbial agents has not been investigated in people with emerging psychosis...
  18. ncbi request reprint Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis
    Belinda Garner
    Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne, Royal Melbourne Hospital, Melbourne, Australia
    Biol Psychiatry 58:417-23. 2005
    ..We examined pituitary volume before the onset of psychosis in subjects who were at ultra-high risk (UHR) for developing psychosis...
  19. ncbi request reprint Incipient neurovulnerability and neuroprotection in early psychosis
    Gregor E Berger
    ORYGEN Research Centre, University of Melbourne, Parkville, Victoria, Australia
    Psychopharmacol Bull 37:79-101. 2003
    ..Neuroprotective strategies counteracting the loss or supporting the generation of progenitor cells may therefore be a potent therapeutic avenue to explore...
  20. ncbi request reprint The transition to psychosis: risk factors and brain changes
    Stephen J Wood
    Epidemiol Psichiatr Soc 13:137-40. 2004
  21. ncbi request reprint Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study
    G Paul Amminger
    Department of Child and Adolescent Neuropsychiatry, Medical University of Vienna, Vienna, Austria
    Biol Psychiatry 61:551-3. 2007
    ..There is increasing evidence that fatty acid deficiencies or imbalances may contribute to childhood neurodevelopmental disorders...
  22. ncbi request reprint Insight, symptoms and executive functions in schizophrenia
    Andor E Simon
    Psychiatric Outpatient Services, Specialised Programme for Early Psychosis, Bruderholz, Switzerland
    Cogn Neuropsychiatry 11:437-51. 2006
    ..We investigated the relationship of insight with executive functions and symptoms in a group of stabilised inpatients with schizophrenia...